miR-1226-3p Promotes Sorafenib Sensitivity of Hepatocellular Carcinoma via Downregulation of DUSP4 Expression

Background: Sorafenib appears to increase the survival rate of hepatocellular carcinoma (HCC) patients, but its response rate is seriously limited due to drug resistance. Molecular mechanisms underlying sorafenib resistance are still unknown. Herein, we explored the possible role of miR-1226-3p in s...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Cancer
Päätekijät: Chen, Xianqing, Tan, Wenliang, Li, Wenxin, Li, Wenda, Zhu, Sicong, Zhong, Jinyi, Shang, Changzhen, Chen, Yajin
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Ivyspring International Publisher 2019
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6584923/
https://ncbi.nlm.nih.gov/pubmed/31258782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.31804
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia